Ischemic Heart Disease: Clinical Trials

35 trials for Ischemic Heart Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 9 unknown, 3 recruiting, 1 not yet recruiting. 35 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 435Completed 22, Unknown 9, Recruiting 3, Not yet recruiting 1

Follow Ischemic Heart Disease: new trials by email Literature Review of Ischemic Heart Disease trials Research Report on Ischemic Heart Disease

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
Continuation of daily low-dose Aspirin, Discontinuation of daily low-dose Aspirin - Ischemic Heart Disease, Ischemic Heart Disease Chronic
Phase 4RecruitingOdense University Hospital70002026-09-302026-10-05
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Adenosine - Chronic Coronary Syndrome, Coronary Artery Disease
Phase 4RecruitingRegion Skane1802024-10-232026-08-13
Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease
Inclisiran - Ischemic Heart Disease, Acute Coronary Syndrome
Phase 4Not yet recruitingJose Seijas Amigo502024-06-012024-05-20
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Aspirin, No aspirin - Stable Angina Pectoris, Coronary Artery Disease
Phase 4RecruitingTakeshi Morimoto28902022-06-142025-03-11
One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease
Aspirin, Atorvastatin, Perindopril - Ischemic Heart Disease
Phase 4UnknownUniversity of Roma La Sapienza1002019-11-012019-11-05
Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease
Allopurinol - Diabetes Mellitus, Ischemic Heart Disease
Phase 4UnknownTel-Aviv Sourasky Medical Center1002018-12-012018-11-21
Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation
Aspirin + clopidogrel, Clopidogrel monotherapy, Aspirin monotherapy - Gastrointestinal Injury, Ischemic Heart Disease
Phase 4CompletedShenyang Northern Hospital7832017-07-132022-05-19
Randomized Anticoagulation Trial in Opcab (RATIO)
Heparin - Ischemic Heart Disease
Phase 4UnknownAzienda Ospedaliera di Lecco9002017-01-012017-05-12
Does the Advice to Eat a Mediterranean Diet With Low Carbohydrate Intake, Compared With a Low-fat Diet, Reduce Diabetes and Cardiovascular Disease?
Advice on what food to choose and eat - Ischemic Heart Disease
Phase 4UnknownUniversity Hospital, Linkoeping12002016-10-012019-04-24
Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
vildagliptin, Dapagliflozin - Diabetes Mellitus, Type 2, Ischemic Heart Disease
Phase 4CompletedChiang Mai University432014-10-012018-07-19
Ranolazine for Improving Symptoms of Palpitations
Ranolazine, Placebo - Ischemic Heart Disease
Phase 4UnknownUniversity of Roma La Sapienza1002014-01-012013-03-07
Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson
Regadenoson - Ischemic Heart Disease
Phase 4CompletedWashington University School of Medicine162013-01-012018-06-15
Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
Metformin plus vildagliptin, Metformin only - Type 2 Diabetes Mellitus, Ischemic Heart Disease
Phase 4CompletedSheba Medical Center602012-09-012016-04-19
The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting
Biomatrix drug eluting stent - Ischemic Heart Disease
Phase 4UnknownZealand University Hospital51002012-03-012012-02-16
The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial
Metformin, Placebo - Cardiovascular Disease, Ischemic Heart Disease
Phase 4CompletedRadboud University Medical Center1002011-11-012014-07-29
Effects of N-acetylcysteine on Low T3 Syndrome
N-acetylcysteine - Acute Myocardial Infarction, Euthyroid Sick Syndrome
Phase 4CompletedFederal University of Rio Grande do Sul832011-11-012015-03-31
Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents
6-month dual anti-platelet therapy, 12-month dual anti-platelet therapy, Zotarolimus eluting stent - Ischemic Heart Disease
Phase 4CompletedGangnam Severance Hospital13682011-05-022017-02-17
Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease
Amlodipine - Ischemic Heart Disease
Phase 4CompletedRuttonjee Hospital972010-07-012012-06-06
Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
Dipyridamole, placebo - Cardiovascular Disease, Ischemic Heart Disease
Phase 4CompletedRadboud University Medical Center952009-12-012013-01-10
PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)
Catheterization, stent deployment - Ischemic Heart Disease
Phase 4CompletedMedinol Ltd.2782009-04-012018-03-27

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Myocardial Ischemia (35)  ·  Acute Coronary Syndrome (3)  ·  Cardiovascular Diseases (3)  ·  Coronary Artery Disease (3)  ·  Angina, Stable (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Heart Failure (2)  ·  Hypertension (2)  ·  Myocardial Infarction (2)  ·  Reperfusion Injury (2)  ·  Stroke (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Angina Pectoris (1)  ·  Angina, Unstable (1)

Broader conditions

Heart Diseases (35)  ·  Vascular Diseases (35)  ·  Cardiovascular Diseases (32)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Pathologic Processes (6)  ·  Endocrine System Diseases (5)  ·  Arterial Occlusive Diseases (4)  ·  Arteriosclerosis (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Chest Pain (3)  ·  Coronary Disease (3)  ·  Neurologic Manifestations (3)  ·  Pain (3)

Interventions

Aspirin (5)  ·  Clopidogrel (3)  ·  Atorvastatin (2)  ·  Metformin (2)  ·  Valsartan (2)  ·  Vildagliptin (2)  ·  ALN-PCS (1)  ·  Acetylcysteine (1)  ·  Adenosine (1)  ·  Allopurinol (1)  ·  Amlodipine (1)  ·  Catheterization (1)  ·  Celecoxib (1)  ·  Cilostazol (1)  ·  Coronary Artery Bypass (1)

Sponsors

Shenyang Northern Hospital (3)  ·  Radboud University Medical Center (2)  ·  University of Florida (2)  ·  University of Roma La Sapienza (2)  ·  Azienda Ospedaliera di Lecco (1)  ·  BSP Biological Signal Processing Ltd. (1)  ·  Chiang Mai University (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Federal University of Rio Grande do Sul (1)  ·  Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy (1)  ·  Gangnam Severance Hospital (1)  ·  Jikei University School of Medicine (1)  ·  Jose Seijas Amigo (1)  ·  Kyoto Prefectural University of Medicine (1)  ·  Medinol Ltd. (1)

Countries

China (5)  ·  Denmark (4)  ·  Italy (4)  ·  Japan (4)  ·  Netherlands (4)  ·  Israel (3)  ·  Sweden (3)  ·  United States (3)  ·  Germany (2)  ·  Poland (2)  ·  Spain (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Finland (1)

Top investigators

Carl J Pepine, MD (2)  ·  Yaling Han, M.D. (2)  ·  Andrew YW Li, MB (1)  ·  Andrzej Bochenek, Prof (1)  ·  Arintaya Phrommintikul, MD (1)  ·  Dan Tzivoni, Professor (1)  ·  Danilo Neglia, MD, PhD (1)  ·  Edoardo Camenzind, MD (1)  ·  Finlay McAlister, MD,MSc (1)  ·  Francesco Pelliccia, MD (1)  ·  Fredrik H Nystrom, MD professor (1)  ·  Giuseppe Marazzi (1)  ·  Gunnar VH Jensen, MD (1)

Results publications

PMID 10400006, PMID 12595860, PMID 15367828, PMID 16098418, PMID 17467513, PMID 19723695, PMID 19933787, PMID 21982660, PMID 22951082, PMID 23118347, PMID 24622709, PMID 24627416, PMID 24890531, PMID 25106761, PMID 25148231, PMID 25307535, PMID 25711274, PMID 25773594, PMID 25910523, PMID 26179504, PMID 28202051, PMID 28335893, PMID 28532406, PMID 31672148, PMID 32588238, PMID 34671067, PMID 37976067, PMID 8540450, PMID 9359541, PMID 9817489

NIH funding

2009 (1), 2023 (1), U01HL064924 (1)